UK “AstraZeneca vaccine is also safe…effective for the elderly”
[뉴스리뷰]
[앵커]
Since the development of the Corona 19 vaccine, as countries have accelerated vaccination, concerns about the effectiveness and safety of the vaccine are also growing.
In the UK and Italy, the results of vaccinations that could dispel these concerns have been released one after another, drawing attention.
This is Kim Hyo-seop PD.
[리포터]
“With the effort of the medical staff and so many people, we are on our way to the goal. It is definitely an important part of getting everyone out of the crisis.”
UK, the first in the world to start vaccination to overcome the COVID-19 crisis.
According to the UK government, the number of people who completed the first dose of the vaccine as of the 3rd has already exceeded 10 million, and by mid-February, it has set a goal of vaccinating 15 million people.
Amid the pace of vaccination, the UK’s independent regulatory agency, Drugs and Health Care Products Regulatory Authority, released the results of a safety analysis of 7 million vaccinations.
The number of side effects was 22,000, which was only 3 out of 1,000 inoculated, and symptoms were also known to be mild.
He stressed that the effectiveness of the AstraZeneca vaccine against the elderly over the age of 65, which has been raised in some countries, such as France and Germany, has been sufficiently proven.
Even in Italy, the vaccine was evaluated as relatively safe.
According to the Italian Medicines Agency, as a result of analyzing 1.56 million cases of Pfizer and Modena vaccination, the number of side effects was 7,300, and the incidence of side effects was less than 0.5%.
By the way, about 92% of the symptoms of side effects showed only mild symptoms such as fatigue and fever, and the data proves the safety of the vaccine, the Italian Medicines Agency explained.
Meanwhile, the head of the EU and EU, which is struggling with vaccines, admitted that there were mistakes in the vaccine supply strategy and underestimated the difficulty of mass production of vaccines.
This is Yonhap News TV Kim Hyo-seop.
Yonhap News TV article inquiries and reports: katok/line jebo23
(End)
–
